Cardiff Oncology, Inc. (CRDF)
USD 4.49
(-16.07%)
USD 4.49
(-16.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 488 Thousand | 386 Thousand | 359 Thousand | 365.99 Thousand | 245 Thousand | 378 Thousand |
| Cost of Revenue | 32.85 Million | 200 Thousand | 500 Thousand | 11.23 Million | 11.16 Million | 597 Thousand |
| Gross Profit | -32.36 Million | 186 Thousand | -141 Thousand | -10.86 Million | -10.91 Million | -219 Thousand |
| Operating Expenses | 45.9 Million | 40.28 Million | 29.21 Million | 19.45 Million | 16.92 Million | 16.17 Million |
| Selling, General and Administrative Expenses | 13.04 Million | 13.18 Million | 11.83 Million | 8.21 Million | 5.76 Million | 8 Million |
| Research and Development Expenses | 32.85 Million | 27.1 Million | 17.37 Million | 11.23 Million | 11.16 Million | 8.16 Million |
| Other Expenses | - | -383 Thousand | 15 Thousand | -28.24 Thousand | 2000.00 | -237 Thousand |
| Cost and Expenses | 45.9 Million | 40.28 Million | 29.21 Million | 19.45 Million | 16.92 Million | 16.76 Million |
| Operating Income | -45.41 Million | -39.9 Million | -28.85 Million | -19.08 Million | -16.67 Million | -17.05 Million |
| Interest Expense | - | 1.58 Million | - | 1519.00 | - | 25.4 Thousand |
| Income Tax Expense | - | -1.19 Million | -549 Thousand | -26.72 Thousand | -262 Thousand | 617.64 Thousand |
| Earnings before Tax | -41.44 Million | -38.7 Million | -28.29 Million | -19.3 Million | -16.41 Million | -16.46 Million |
| Net Income | -41.44 Million | -37.5 Million | -27.74 Million | -19.27 Million | -16.15 Million | -16.46 Million |
| Earnings Per Share Basic | -0.93 | -0.86 | -0.71 | -0.92 | -2.70 | -7.06 |
| Earnings Per Share Diluted | -0.93 | -0.86 | -0.71 | -0.92 | -2.70 | -7.06 |
| Weighted Average Shares Outstanding | 44.67 Million | 43.6 Million | 39.03 Million | 20.87 Million | 5.97 Million | 2.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.67 Million | 43.6 Million | 39.03 Million | 20.87 Million | 5.97 Million | 2.33 Million |
| Gross Margin | -66.33 | 0.48 | -0.39 | -29.70 | -44.56 | -0.58 |
| EBIT Margin | -92.24 | -102.76 | -79.91 | -50.71 | -66.17 | -41.01 |
| Profit Margin | -84.92 | -97.17 | -77.28 | -52.68 | -65.93 | -43.55 |
| EBITDA | -45.01 Million | -39.66 Million | -28.4 Million | -18.83 Million | -15.91 Million | -15.69 Million |
| Earnings Before Tax Margin | -93.06 | -103.37 | -80.38 | -52.15 | -68.07 | -45.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 163 Thousand | 205 Thousand | 156 Thousand | 488 Thousand | 141 Thousand | 108 Thousand |
| Cost of Revenue | 105 Thousand | 102 Thousand | 103 Thousand | 398 Thousand | 107 Thousand | 98 Thousand |
| Gross Profit | 58 Thousand | 103 Thousand | 53 Thousand | 90 Thousand | 34 Thousand | 10 Thousand |
| Operating Expenses | 12.6 Million | 11.03 Million | 10.38 Million | 45.5 Million | 10.96 Million | 12.31 Million |
| Selling, General and Administrative Expenses | 3.11 Million | 3.02 Million | 2.62 Million | - | 2.93 Million | 4.29 Million |
| Research and Development Expenses | 9.49 Million | 8 Million | 7.76 Million | - | 8.02 Million | 8.02 Million |
| Other Expenses | -38 Thousand | -4000.00 | -13 Thousand | -98 Thousand | 21 Thousand | 5000.00 |
| Cost and Expenses | 12.7 Million | 11.13 Million | 10.48 Million | 45.9 Million | 10.96 Million | 12.31 Million |
| Operating Income | -12.54 Million | -10.93 Million | -10.33 Million | -45.41 Million | -10.82 Million | -12.2 Million |
| Interest Expense | - | - | 829 Thousand | - | - | - |
| Income Tax Expense | - | 58.72 Thousand | 2.95 Million | 230.1 Thousand | -1.06 Million | -1.05 Million |
| Earnings before Tax | -11.77 Million | -10.01 Million | -9.33 Million | -41.44 Million | -9.73 Million | -11.15 Million |
| Net Income | -11.77 Million | -10.01 Million | -9.33 Million | -41.44 Million | -9.73 Million | -11.15 Million |
| Earnings Per Share Basic | -0.26 | -0.22 | -0.21 | - | -0.22 | -0.25 |
| Earnings Per Share Diluted | -0.26 | -0.22 | -0.21 | - | -0.22 | -0.25 |
| Weighted Average Shares Outstanding | 44.82 Million | 44.67 Million | 44.67 Million | 44.67 Million | 44.67 Million | 44.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.82 Million | 44.67 Million | 44.67 Million | 44.67 Million | 44.67 Million | 44.67 Million |
| Gross Margin | 0.36 | 0.50 | 0.34 | 0.18 | 0.24 | 0.09 |
| EBIT Margin | -76.32 | -52.83 | -65.57 | - | -75.98 | -112.13 |
| Profit Margin | -72.26 | -48.83 | -59.85 | -84.92 | -69.01 | -103.24 |
| EBITDA | -12.44 Million | -10.83 Million | -10.22 Million | - | -10.71 Million | -12.11 Million |
| Earnings Before Tax Margin | -76.96 | -53.33 | -66.23 | -93.06 | -76.74 | -113.04 |
ALLE
6331
HOTLSILV
FCCTP
VEERENRGY
9064